NASHVILLE, Tenn., Sept. 11, 2019 /PRNewswire/ -- Tennessee Gov. Bill Lee, Department of Economic and Community Development Commissioner Bob Rolfe and HCTec officials announced today that the company will continue to expand its operations in Hohenwald

BAUDETTE, Minn., Sept. 11, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Vancomycin HCl for Oral Solution, 250mg per 5mL (the generic equivalent to ANI's Vancocin® for Oral Solution).  To facilitate ease of administration the drug now includes a mixed berry taste, can be administered via nasogastric

CARLSBAD, Calif., Sept. 11, 2019 /PRNewswire/ -- In partnership with Scientis, a Swiss dermatology company dedicated to developing novel dermo-cosmetic solutions to address skin pigmentation concerns, SENTÉ expands its portfolio of physician exclusive skincare solutions in the United States with the introduction of Cyspera, a novel

BALTIMORE, Sept. 11, 2019 /PRNewswire/ -- The Body Image Therapy Center, a nationally-recognized eating disorder treatment center, is now proud to offer residential living accommodations near their Baltimore, MD location. Clients in the partial hospitalization program (PHP) or intensive outpatient program (IOP) have access to safe, a

LAS VEGAS, Sept. 11, 2019 /PRNewswire/ -- Appliance Recycling Centers of America, Inc. (NASDAQ: JAN) today announced that, on September 10, 2019, the company has been renamed JanOne Inc. and, effective this morning, now trades under the ticker symbol JAN, with a new CUSIP number (47089W 104). The company previously announced on

BALTIMORE, Sept. 11, 2019 /PRNewswire/ -- Building on previous progress in the NIH Blueprint Neurotherapeutics program, AgeneBio today announced it has received significant additional resources to accelerate the development of their GABA-A a5  Positive Allosteric Modulation (PAM), a novel approach to mild cognitive impairment (MCI) due to Alzheimer's Disease (AD) th

SAN DIEGO, Sept. 11, 2019 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the developme

STRASBOURG, France, Sept. 11, 2019 /PRNewswire/ -- Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that the company will be presenting at the 3rd Annual Chardan Genetic Medicines Conference being held October 7th-O

HAIKOU CITY, China, Sept. 11, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," "CPHI", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it has entered into a M

FOXBOROUGH, Mass., Sept. 11, 2019 /PRNewswire/ -- Viant, a leading global services provider to the medical device industry, announced today that it has acquired Meraqi Medical. It is the fourth acquisition that Viant has completed in two years to expand its clinical market expertise, global footprint, and portfolio of solutions.